Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT05970666Phase 2Recruiting
Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma
AdebrelimabBevacizumabHepatocellular Carcinoma+2 more
StudydirectorStart date: 2023-11-15

Research Network

Collaboration Network

27 collaborators·41 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Sanming Second Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jiafei Chen

Putian First Hospital

Similar
1 trials

Shared therapeutic areas:

AdebrelimabBevacizumabCarcinoma, Hepatocellular+2 more

Worked with same sponsors:

Jiangsu HengRui Medicine Co., Ltd.The First Affiliated Hospital of Xiamen University
Collaborated on 1 trial
Similarity Score54%

Feng Ye

The First Affiliated Hospital of Xiamen University

Similar
4 trials

Shared therapeutic areas:

AdebrelimabBevacizumabCarcinoma, Hepatocellular+2 more

Worked with same sponsors:

Jiangsu HengRui Medicine Co., Ltd.The First Affiliated Hospital of Xiamen University
Collaborated on 1 trial
Similarity Score54%

Jianbo Chen

The First Affiliated Hospital of Xiamen University

Similar
1 trials

Shared therapeutic areas:

AdebrelimabBevacizumabCarcinoma, Hepatocellular+2 more

Worked with same sponsors:

Jiangsu HengRui Medicine Co., Ltd.The First Affiliated Hospital of Xiamen University
Collaborated on 1 trial
Similarity Score54%

Qinghe Cai

The Affiliated Hospital of Putian University

Similar
1 trials

Shared therapeutic areas:

AdebrelimabBevacizumabCarcinoma, Hepatocellular+2 more

Worked with same sponsors:

Jiangsu HengRui Medicine Co., Ltd.The First Affiliated Hospital of Xiamen University
Collaborated on 1 trial
Similarity Score54%

congren Wang

Quanzhou First Hospital

Similar
1 trials

Shared therapeutic areas:

AdebrelimabBevacizumabCarcinoma, Hepatocellular+2 more

Worked with same sponsors:

Jiangsu HengRui Medicine Co., Ltd.The First Affiliated Hospital of Xiamen University
Collaborated on 1 trial
Similarity Score54%

Feng Lin

Ningde Mindong Hospital

Similar
2 trials

Shared therapeutic areas:

Carcinoma, HepatocellularAdebrelimabBevacizumab+2 more

Worked with same sponsors:

Jiangsu HengRui Medicine Co., Ltd.The First Affiliated Hospital of Xiamen University
Collaborated on 1 trial
Similarity Score54%

Feng duan, MD

Chinese PLA General Hospital

Related
10 trials

Shared therapeutic areas:

Carcinoma, HepatocellularBevacizumab
Similarity Score12%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular
Similarity Score6%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular
Similarity Score6%

Ming Shi, MD

Sun Yat-sen University

Related
11 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05970666Phase 2StudyDirector

Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma

AdebrelimabBevacizumabHepatocellular Carcinoma+2 more
Recruiting

All 1 trials loaded